LivQ-box® Parameters in the Diagnosis of Liver Inflammation
Recruiting · NCT06802731 · Observational (researchers observe without assigning treatment) · Lead sponsor: Wuxi Hisky Medical Technology Co Ltd
View the official record on ClinicalTrials.gov →What this trial is about
To evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients diagnosed with NAFLD according to The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases;
- Age over 18 years old, gender not limited;
- Not combined with liver diseases (such as viral hepatitis, drug-induced liver injury, autoimmune liver disease);
- Perform iLivTouch examination within ± 14 days of liver pathology examination;
- No history of excessive alcohol consumption (converted to ethanol:\<140g/week for males,\<70g/week for females);
Where it is running
1 location listed.
- Beijing Tsinghua Changgung Hospital (BTCH) affiliated to Tsinghua University - Beijing, Beijing Municipality, China